Paul M. O'byrne

Paul M. O'byrne

St. Joseph's Hospital
Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 247 publications

FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.

FeNO as a Treatable Trait in Chronic Cough: Insights from the PROCOUGH Study.

Journal: Lung
Published: June 12, 2026

An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics.

An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics.

Journal: Advances in therapy
Published: May 13, 2026

Identifying and addressing problematic studies in allergy and asthma research: a commentary.

Identifying and addressing problematic studies in allergy and asthma research: a commentary.

Journal: The journal of allergy and clinical immunology. In practice
Published: May 08, 2026

Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

Moving Beyond Responders: A Post Hoc Analysis Identifying Criteria for Chronic Cough Control.

Journal: Chest
Published: March 31, 2026

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Prospective study to evaluate the effectiveness of guideline-based therapy for chronic cough and refractory chronic cough: PROCOUGH.

Journal: ERJ open research
Published: February 18, 2026

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.

Journal: The European respiratory journal
Published: January 19, 2026

Prevalence and risk factors for refractory and untreated chronic cough in the Canadian Longitudinal Study of Aging.

Prevalence and risk factors for refractory and untreated chronic cough in the Canadian Longitudinal Study of Aging.

Journal: ERJ open research
Published: November 27, 2025

Macrolides for asthma: A systematic review and meta-analysis of randomized trials.

Macrolides for asthma: A systematic review and meta-analysis of randomized trials.

Journal: The Journal of allergy and clinical immunology
Published: November 23, 2025

Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).

Elarekibep, an inhaled anti-IL-4 receptor alpha Anticalin, in moderate-to-severe asthma: a randomized, placebo-controlled phase 2a study (APATURA).

Journal: Respiratory research
Published: October 24, 2025

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

The AIM4 Next Step study: Comparing inhaled corticosteroid dose escalation to dupilumab in patients with uncontrolled asthma and type 2 inflammation.

Journal: The journal of allergy and clinical immunology. Global
Published: October 20, 2025

Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms.

Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms.

Journal: The journal of allergy and clinical immunology. Global
Published: September 16, 2025

Improved asthma outcomes with dupilumab plus medium-dose inhaled corticosteroids vs placebo plus high-dose inhaled corticosteroids.

Improved asthma outcomes with dupilumab plus medium-dose inhaled corticosteroids vs placebo plus high-dose inhaled corticosteroids.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: September 04, 2025
Showing 1-12 of 247

Last Updated: 09/26/2026